Regor Therapeutics’ $90 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal.Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to treat…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now